SCHEMBL22837886

SCHEMBL22837886

Nc1ncnc2c1ncn2[C@@]1(O)CO[C@H](CNS(=O)(=O)NC2(c3ccccc3F)COC2)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22837884 0.92 GMPS (0.34) —
SCHEMBL22837885 0.92 TRPM2 (0.36) —
SCHEMBL22837937 0.85 — —
SCHEMBL22837935 0.82 TRPM2 (0.36) —
SCHEMBL20711325 0.82 — —
SCHEMBL22837897 0.80 TRPM2 (0.41) —
SCHEMBL22837899 0.76 TRPM2 (0.42) —
SCHEMBL22837883 0.76 ADORA3 (0.37) —
SCHEMBL20097184 0.75 — —
SCHEMBL22837900 0.75 ADORA3 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-12-29 — — US disclosed
Send feedback